Norwegian Cruise Line Holdings Confirms Newbuild Order for Third Prestige-Class Ship for Regent Seven Seas Cruises GlobeNewswire November 10, 2025 MIAMI, Nov. 10, 2025 (GLOBE NEWSWIRE) — Norwegian Cruise Line Holdings Ltd. (NYSE: NCLH), a leading global cruise company operating Norwegian Cruise Line, Oceania Cruises, and Regent Seven Seas Cruises, today announced it has confirmed […]

HCW Biologics Shares the Latest Data for its Second-Generation Immune Checkpoint Inhibitor Presented at the 40th Annual Meeting of the Society for Immunotherapy of Cancer HCW11-040 is a first-in-class pembrolizumab-based, tetra-valent immune checkpoint inhibitor designated as Company's franchise immunotherapeutic for internal clinical development GlobeNewswire November 10, 2025 MIRAMAR, Fla., Nov. 10, 2025 (GLOBE NEWSWIRE) —

Pixalate's October 2025 United Kingdom Publisher Rankings: Top Mobile 'Sports' Apps For Programmatic Advertising Traffic Quality in the Apple App Store and Google Play Store GlobeNewswire November 10, 2025 According to Pixalate's October 2025 rankings, 'OneFootball: All Soccer Scores' was No. 1 on Apple App Store, and 'LiveScore: Live Sports Scores' was top-ranked on Google

AirBoss Announces New Order Valued at up to US$8.1M for Canadian Department of National Defense GlobeNewswire November 10, 2025 NEWMARKET, Ontario, Nov. 10, 2025 (GLOBE NEWSWIRE) — AirBoss of America Corp. (TSX: BOS) (OTCQX:ABSSF) (the “Company” or “AirBoss”) today announced that AirBoss Defense Group (“ADG”), AirBoss Manufactured Products' (“AMP”) defense business, has received an order

Howard Hughes Holdings Inc. Reports Third Quarter 2025 Results Strong land sales lead record results across all segments, supporting upward revision to full-year guidance; $1.4 billion in condominium pre-sales reinforce Company's long-term cash-flow outlook GlobeNewswire November 10, 2025 THE WOODLANDS, Texas, Nov. 10, 2025 (GLOBE NEWSWIRE) — Howard Hughes Holdings Inc. (NYSE: HHH) (the “Company,”

(NasdaqGM:SEPN), SEP-479 Selected as Next-Generation Oral PTH1R Agonist Development Candidate SEP-631 (MRGPRX2 NAM) Phase 1 Clinical Trial in Healthy Volunteers Ongoing Robust Financial Position of $561.6 Million Expected to Support Operations at Least into 2029 SOUTH SAN FRANCISCO, Calif., Nov. 10, 2025 (GLOBE NEWSWIRE) — Septerna, Inc. (Nasdaq: SEPN), a clinical-stage biotechnology company pioneering a

(NasdaqGM:APGE), Interim Phase 1 results for APG333 exceeded trial objectives, demonstrated a half-life of approximately 55 days, and suppressed key biomarkers for 6 months following a single dose, supporting potential 3- and 6- month dosing Results support development of a quarterly or less frequently dosed co-formulation of APG273 (APG777+APG333) for respiratory indications APG333 was well

(NASDAQ:PESI), ATLANTA, Nov. 10, 2025 (GLOBE NEWSWIRE) — Perma-Fix Environmental Services, Inc. (NASDAQ: PESI) (the “Company”) today announced financial results for the third quarter ended September 30, 2025, and provided a business update. Mark Duff, President and Chief Executive Officer (CEO) of the Company, commented, “We are pleased to report improved performance driven by a

(TSX-V:ZAC),(Pinksheets:ZCTSF),(PinkSheets:ZCTSF),(Boerse Frankfurt – Freiverkehr:7TV),(Boerse Frankfurt – Freiverkehr:7TV.F),(TSX:MDI), VANCOUVER, British Columbia, Nov. 10, 2025 (GLOBE NEWSWIRE) — Zacatecas Silver Corp. (TSXV: ZAC; OTC: ZCTSF; FSE: 7TV) is pleased to announce that it has entered into a new community access agreement with the Ejido Panuco at its flagship Zacatecas Silver Project in Zacatecas, Mexico. The Company has

Septerna Highlights Company Progress and Reports Third Quarter 2025 Financial Results GlobeNewswire November 10, 2025 SEP-479 Selected as Next-Generation Oral PTH1R Agonist Development Candidate SEP-631 (MRGPRX2 NAM) Phase 1 Clinical Trial in Healthy Volunteers Ongoing Robust Financial Position of $561.6 Million Expected to Support Operations at Least into 2029 SOUTH SAN FRANCISCO, Calif., Nov. 10,